pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

2,612 catalysts · 5,063 phase readout · 2,335 8k filing · 283 earnings · 277 pdufa · 115 phase 2 completion · 53 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 21 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 0 catalysts2026-10-22: 1 catalyst2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: 8k filing×type: pdufa×clear all
type
  • phase readout5,063
  • 8k filing2,335
  • earnings283
  • pdufa277
  • phase 2 completion115
  • phase 1 completion53
phase 1 2 completion
28
  • phase 1 initiation26
  • phase 0 trial completion22
  • phase 1 2 initiation9
  • therapy area

    no tagged catalysts yet

    Week of Apr 27, 2026

    50
    ›Apr 29, 2026pdufa91d agoSanofi — teplizumab (PDUFA)teplizumab

    Therapy area: Metabolic Disorders. Indication: Type 1 Diabetes (Juvenile Diabetes)

    full page →teplizumab →source: globaldata
    ›Apr 29, 20268k filing91d ago$BIIB — BIOGEN INC. (BIIB) — 8-K filing

    Items: 2.02, 9.01

    full page →edgar 8k ↗
    ›Apr 29, 20268k filing91d ago$IONS — IONIS PHARMACEUTICALS INC (IONS) — 8-K filing

    Items: 2.02, 9.01

    full page →edgar 8k ↗
    ›Apr 29, 20268k filing91d agoTEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA, TEVJF) — 8-K filing

    Items: 2.02, 7.01, 9.01

    full page →edgar 8k ↗
    ›Apr 29, 20268k filing91d ago$AGIO — AGIOS PHARMACEUTICALS, INC. (AGIO) — 8-K filing

    Items: 2.02, 9.01

    full page →edgar 8k ↗
    ›Apr 29, 20268k filing91d ago$REGN — REGENERON PHARMACEUTICALS, INC. (REGN) — 8-K filing

    Items: 2.02, 9.01

    full page →edgar 8k ↗
    ›Apr 29, 20268k filing91d ago$AMRN — AMARIN CORP PLC\UK (AMRN) — 8-K filing

    Items: 2.02, 9.01

    full page →edgar 8k ↗
    ›Apr 29, 20268k filing91d ago$TNXP — Tonix Pharmaceuticals Holding Corp. (TNXP) — 8-K filing

    Items: 7.01, 8.01, 9.01

    full page →edgar 8k ↗
    ›Apr 29, 20268k filing91d ago$ABBV — AbbVie Inc. (ABBV) — 8-K filing

    Items: 2.02, 9.01

    full page →edgar 8k ↗
    ›Apr 29, 20268k filing91d ago$ANIK — Anika Therapeutics, Inc. (ANIK) — 8-K filing

    Items: 2.02, 5.02, 9.01

    full page →edgar 8k ↗
    ›Apr 29, 20268k filing91d ago$NVNO — enVVeno Medical Corp (NVNO) — 8-K filing

    Items: 2.02, 7.01, 8.01, 9.01

    full page →edgar 8k ↗
    ›Apr 29, 20268k filing91d ago$SGMO — SANGAMO THERAPEUTICS, INC (SGMO) — 8-K filing

    Items: 3.01

    full page →edgar 8k ↗
    ›Apr 29, 20268k filing91d ago$KALV — KalVista Pharmaceuticals, Inc. (KALV) — 8-K filing

    Items: 1.01, 7.01, 9.01

    full page →edgar 8k ↗
    ›Apr 29, 20268k filing91d ago$GKOS — GLAUKOS Corp (GKOS) — 8-K filing

    Items: 2.02, 7.01, 9.01

    full page →edgar 8k ↗
    ›Apr 29, 20268k filing91d ago$FEMY — FEMASYS INC (FEMY) — 8-K filing

    Items: 5.07

    full page →edgar 8k ↗
    ›Apr 29, 20268k filing91d ago$PODD — INSULET CORP (PODD) — 8-K filing

    Items: 7.01, 9.01

    full page →edgar 8k ↗
    ›Apr 29, 20268k filing91d ago$VRTX — VERTEX PHARMACEUTICALS INC / MA (VRTX) — 8-K filing

    Items: 5.02

    full page →edgar 8k ↗
    ›Apr 29, 20268k filing91d ago$MDXG — MIMEDX GROUP, INC. (MDXG) — 8-K filing

    Items: 2.02, 7.01, 9.01

    full page →edgar 8k ↗
    ›Apr 29, 20268k filing91d ago$MPLT — MapLight Therapeutics, Inc. (MPLT) — 8-K filing

    Items: 5.02

    full page →edgar 8k ↗
    ›Apr 29, 20268k filing91d ago$LUNG — Pulmonx Corp (LUNG) — 8-K filing

    Items: 2.02

    full page →edgar 8k ↗
    ›Apr 29, 20268k filing91d ago$PRCT — PROCEPT BioRobotics Corp (PRCT) — 8-K filing

    Items: 2.02, 9.01

    full page →edgar 8k ↗
    ›Apr 29, 20268k filing91d ago$BDX — BECTON DICKINSON & CO (BDX) — 8-K filing

    Items: 5.03, 9.01

    full page →edgar 8k ↗
    ›Apr 29, 20268k filing91d ago$IVF — INVO Fertility, Inc. (IVF) — 8-K filing

    Items: 3.01, 7.01, 9.01

    full page →edgar 8k ↗
    ›Apr 29, 20268k filing91d ago$CBIO — CRESCENT BIOPHARMA, INC. (CBIO) — 8-K filing

    Items: 2.02, 9.01

    full page →edgar 8k ↗
    ›Apr 29, 20268k filing91d ago$BHC — Bausch Health Companies Inc. (BHC) — 8-K filing

    Items: 2.02, 9.01

    full page →edgar 8k ↗
    ›Apr 29, 20268k filing91d ago$HIND — Vyome Holdings, Inc (HIND) — 8-K filing

    Items: 5.03, 5.07, 9.01

    full page →edgar 8k ↗
    ›Apr 29, 20268k filing91d ago$VKTX — Viking Therapeutics, Inc. (VKTX) — 8-K filing

    Items: 2.02, 9.01

    full page →edgar 8k ↗
    ›Apr 29, 20268k filing91d ago$BBOT — BridgeBio Oncology Therapeutics, Inc. (BBOT) — 8-K filing

    Items: 5.02

    full page →edgar 8k ↗
    ›Apr 29, 20268k filing91d ago$SDEV — Stablecoin Development Corp (SDEV) — 8-K filing

    Items: 4.02

    full page →edgar 8k ↗
    ›Apr 29, 20268k filing91d agoTriSalus Life Sciences, Inc. (TLSI, TLSIW) — 8-K filing

    Items: 5.02

    full page →edgar 8k ↗
    ›Apr 29, 20268k filing91d ago$OLMA — Olema Pharmaceuticals, Inc. (OLMA) — 8-K filing

    Items: 5.02, 7.01, 9.01

    full page →edgar 8k ↗
    ›Apr 29, 20268k filing91d ago$ASRT — Assertio Holdings, Inc. (ASRT) — 8-K filing

    Items: 7.01, 9.01

    full page →edgar 8k ↗
    ›Apr 29, 20268k filing91d ago$CTXR — Citius Pharmaceuticals, Inc. (CTXR) — 8-K filing

    Items: 3.02, 8.01, 9.01

    full page →edgar 8k ↗
    ›Apr 29, 20268k filing91d ago$CTOR — CITIUS ONCOLOGY, INC. (CTOR) — 8-K filing

    Items: 8.01, 9.01

    full page →edgar 8k ↗
    ›Apr 29, 20268k filing91d ago$PMHS — Polomar Health Services, Inc. (PMHS) — 8-K filing

    Items: 1.02, 9.01

    full page →edgar 8k ↗
    ›Apr 29, 20268k filing91d agoProfusa, Inc. (PFSA, NVACW) — 8-K filing

    Items: 1.01, 2.03, 3.01, 3.03, 9.01

    full page →edgar 8k ↗
    ›Apr 29, 20268k filing91d ago$AUTL — Autolus Therapeutics plc (AUTL) — 8-K filing

    Items: 2.05, 7.01, 9.01

    full page →edgar 8k ↗
    ›Apr 30, 2026pdufa90d agoAxsome Therapeutics Inc — (bupropion hydrochloride + dextromethorphan) ER (PDUFA)(bupropion hydrochloride + dextromethorphan) ER

    Therapy area: Central Nervous System. Indication: Dementia Associated With Alzheimer's Disease

    full page →(bupropion hydrochloride + dextromethorphan) ER →source: globaldata
    ›Apr 30, 20268k filing90d ago$HCWB — HCW Biologics Inc. (HCWB) — 8-K filing

    Items: 8.01, 9.01

    full page →edgar 8k ↗
    ›Apr 30, 20268k filing90d ago$BCYC — BICYCLE THERAPEUTICS PLC (BCYC) — 8-K filing

    Items: 2.02, 9.01

    full page →edgar 8k ↗
    ›Apr 30, 20268k filing90d ago$RNAC — Cartesian Therapeutics, Inc. (RNAC) — 8-K filing

    Items: 2.02, 9.01

    full page →edgar 8k ↗
    ›Apr 30, 20268k filing90d ago$QURE — uniQure N.V. (QURE) — 8-K filing

    Items: 7.01, 9.01

    full page →edgar 8k ↗
    ›Apr 30, 20268k filing90d ago$KYMR — Kymera Therapeutics, Inc. (KYMR) — 8-K filing

    Items: 2.02, 9.01

    full page →edgar 8k ↗
    ›Apr 30, 20268k filing90d ago$LLY — ELI LILLY & Co (LLY) — 8-K filing

    Items: 2.02, 9.01

    full page →edgar 8k ↗
    ›Apr 30, 20268k filing90d ago$NVCR — NovoCure Ltd (NVCR) — 8-K filing

    Items: 2.02, 9.01

    full page →edgar 8k ↗
    ›Apr 30, 20268k filing90d agoBRISTOL MYERS SQUIBB CO (BMY, CELG-RI) — 8-K filing

    Items: 2.02, 7.01, 9.01

    full page →edgar 8k ↗
    ›Apr 30, 20268k filing90d ago$PYXS — Pyxis Oncology, Inc. (PYXS) — 8-K filing

    Items: 5.02

    full page →edgar 8k ↗
    ›Apr 30, 20268k filing90d ago$PHAT — Phathom Pharmaceuticals, Inc. (PHAT) — 8-K filing

    Items: 2.02, 9.01

    full page →edgar 8k ↗
    ›Apr 30, 20268k filing90d ago$INDV — Indivior Pharmaceuticals, Inc. (INDV) — 8-K filing

    Items: 2.02, 7.01, 9.01

    full page →edgar 8k ↗
    ›Apr 30, 20268k filing90d ago$BAX — BAXTER INTERNATIONAL INC (BAX) — 8-K filing

    Items: 2.02, 8.01, 9.01

    full page →edgar 8k ↗
    ← prev
    page 1 of 53
    next →
    $SNY44.00+1.50%
    $AXSM238.37-1.09%